We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+7.89%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$314B
AUM Growth
+$19.1B
Cap. Flow
+$92.3M
Cap. Flow %
0.03%
Top 10 Hldgs %
20.84%
Holding
3,440
New
118
Increased
1,247
Reduced
1,874
Closed
82

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.37B
2
DD icon
DuPont de Nemours
DD
+$556M
3
QCOM icon
Qualcomm
QCOM
+$405M
4
MRK icon
Merck
MRK
+$333M
5
TSM icon
TSMC
TSM
+$315M

Sector Composition

Rank Sector Weight
1 Technology 23.31%
2 Consumer Discretionary 12.98%
3 Financials 12.81%
4 Healthcare 12.54%
5 Communication Services 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCC icon
2276
Warrior Met Coal
HCC
$4.86B
$3.76M ﹤0.01%
219,302
+2,700
+1% +$57K
RDNT icon
2277
RadNet
RDNT
$5.69B
$3.75M ﹤0.01%
172,465
-20,893
-11% -$423K
AGX icon
2278
Argan
AGX
$8.37B
$3.75M ﹤0.01%
70,200
-1,677
-2% -$80.8K
CKH
2279
DELISTED
Seacor Holdings Inc.
CKH
$3.74M ﹤0.01%
91,762
-2,480
-3% -$104K
IVV icon
2280
iShares Core S&P 500 ETF
IVV
$904B
$3.74M ﹤0.01%
9,390
FLXN
2281
DELISTED
Flexion Therapeutics, Inc.
FLXN
$3.73M ﹤0.01%
416,874
-25,982
-6% -$298K
ORAN
2282
DELISTED
Orange
ORAN
$3.73M ﹤0.01%
302,093
-24,779
-8% -$299K
FMTX
2283
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$3.72M ﹤0.01%
132,804
+68,232
+106% +$2.46M
ACCO icon
2284
Acco Brands
ACCO
$407M
$3.71M ﹤0.01%
439,752
-21,136
-5% -$182K
MBT
2285
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$3.71M ﹤0.01%
444,542
-85,100
-16% -$748K
MDGL icon
2286
Madrigal Pharmaceuticals
MDGL
$11.8B
$3.7M ﹤0.01%
31,641
-30
-0.1% -$3.5K
VNDA icon
2287
Vanda Pharmaceuticals
VNDA
$302M
$3.69M ﹤0.01%
245,749
-6,389
-3% -$103K
HSII
2288
DELISTED
Heidrick & Struggles
HSII
$3.69M ﹤0.01%
103,150
-3,306
-3% -$112K
VEA icon
2289
Vanguard FTSE Developed Markets ETF
VEA
$237B
$3.68M ﹤0.01%
75,000
VERU icon
2290
Veru
VERU
$37.4M
$3.68M ﹤0.01%
34,117
+8,159
+31% +$1.03M
CNA icon
2291
CNA Financial
CNA
$14.1B
$3.63M ﹤0.01%
81,418
+26,062
+47% +$1.11M
ARR
2292
Armour Residential REIT
ARR
$2.36B
$3.63M ﹤0.01%
59,512
-328
-0.5% -$19.2K
KRRO icon
2293
Korro Bio
KRRO
$195M
$3.62M ﹤0.01%
1,995
-3
-0.2% -$5.83K
PRVB
2294
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$3.62M ﹤0.01%
344,866
+3,137
+0.9% +$44.1K
SLP icon
2295
Simulations Plus
SLP
$371M
$3.61M ﹤0.01%
57,011
+4,160
+8% +$305K
EBIX
2296
DELISTED
Ebix Inc
EBIX
$3.6M ﹤0.01%
112,528
+259
+0.2% +$9.99K
STRL icon
2297
Sterling Infrastructure
STRL
$16.7B
$3.6M ﹤0.01%
155,223
-58,491
-27% -$1.27M
CBB
2298
DELISTED
Cincinnati Bell Inc.
CBB
$3.6M ﹤0.01%
234,583
+5,268
+2% +$80.6K
ASIX icon
2299
AdvanSix
ASIX
$444M
$3.6M ﹤0.01%
134,110
+1,292
+1% +$33K
BNFT
2300
DELISTED
Benefitfocus, Inc.
BNFT
$3.59M ﹤0.01%
260,172
-58,949
-18% -$848K

Similar funds

Nuveen's Q1 2021 Portfolio in Review

As of Q1 2021, Nuveen held 3,440 positions worth $314B, up 6.5% from $295B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nuveen's Q1 2021 filing shows 118 new, 1,247 increased, 1,874 reduced and 82 closed positions. Its largest new stake was Coupang: 6,313,287 shares worth $312M. The largest sale was Apple, an estimated $1.37B.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Nuveen's largest Q1 2021 buy was Coupang: 6,313,287 shares worth $312M.
  • Nuveen added most to Intel in Q1 2021, an estimated $905M increase.
  • Nuveen's biggest Q1 2021 reduction was Apple, cutting an estimated $1.37B.
  • Nuveen fully exited PARSLEY ENERGY INC in Q1 2021, selling an estimated $122M.
  • Nuveen's ten largest holdings make up 21% of its $314B portfolio in Q1 2021.
  • Nuveen opened 118 new positions and closed 82 in Q1 2021.
  • Nuveen's portfolio value rose 6.5% quarter-over-quarter to $314B.

Based on Nuveen's 13F filing for Q1 2021, filed 17 May 2021.